Cargando…

Targeted Therapy of Hepatitis B Virus-Related Hepatocellular Carcinoma: Present and Future

Cancer immunotherapy using a patient’s own T cells redirected to recognize and kill tumor cells has achieved promising results in metastatic melanoma and leukemia. This technique involves harnessing a patient’s T cells and then delivering a gene that encodes a new T cell receptor (TCR) or a chimeric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koh, Sarene, Tan, Anthony Tanoto, Li, Lietao, Bertoletti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5456313/ https://www.ncbi.nlm.nih.gov/pubmed/28933390 http://dx.doi.org/10.3390/diseases4010010

Ejemplares similares

A Practical Approach to Immunotherapy of Hepatocellular Carcinoma Using T Cells Redirected Against Hepatitis B Virus
por: Koh, Sarene, et al.
Publicado: (2013)

Challenges of CAR- and TCR-T cell–based therapy for chronic infections
por: Bertoletti, Antonio, et al.
Publicado: (2020)

Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection
por: Gehring, Adam J., et al.
Publicado: (2011)

Hepatitis B: future curative strategies
por: Bertoletti, Antonio, et al.
Publicado: (2014)

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)

Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial
por: Meng, Fanping, et al.
Publicado: (2021)

Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Rizzo, Giacomo Emanuele Maria, et al.
Publicado: (2022)

Immunotherapy for Chronic Hepatitis B Virus Infection
por: Bertoletti, Antonio, et al.
Publicado: (2018)

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8(+) and CD4(+) T cells of broad specificity
por: Lim, Joey Ming Er, et al.
Publicado: (2022)

Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection
por: Khakpoor, Atefeh, et al.
Publicado: (2019)

Hepatitis B Virus Cure: Targets and Future Therapies
por: Lee, Hye Won, et al.
Publicado: (2020)

Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
por: Bertoletti, Antonio, et al.
Publicado: (2013)

Hepatitis B Virus and Primary Hepatocellular Carcinoma
por: Sutton, R. N. P.
Publicado: (1982)

Hepatitis B and C Viruses and Hepatocellular Carcinoma
por: Bartosch, Birke
Publicado: (2010)

Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes
por: Tham, Christine Y.L., et al.
Publicado: (2020)

Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells
por: Ceccarello, Erica, et al.
Publicado: (2021)

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
por: Shokrgozar, Zahra, et al.
Publicado: (2012)

Analysis of hepatocellular carcinoma associated with hepatitis B virus
por: Zheng, Litao
Publicado: (2023)

Chemotherapy for hepatocellular carcinoma: The present and the future
por: Le Grazie, Marco, et al.
Publicado: (2017)

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma: A new perspective in bioinformatics
por: Wang, Yang, et al.
Publicado: (2021)

Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
por: Kim, Jung Hee, et al.
Publicado: (2016)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
por: Pasetto, Anna, et al.
Publicado: (2012)

Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma
por: Yang, Suh Yoon, et al.
Publicado: (2014)

HBx Gene Mutations in Hepatitis B Virus and Hepatocellular Carcinoma
por: Mathew M, Anumol, et al.
Publicado: (2014)

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
por: Bonilla, Cecilia Monge, et al.
Publicado: (2020)

Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma
por: Andrisani, Ourania
Publicado: (2021)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress
por: Noverati, Nicholas, et al.
Publicado: (2022)

Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role as a Potential Target for Future Therapies
por: Ali, Esraa, et al.
Publicado: (2022)

Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells
por: Mani, Saravana Kumar Kailasam, et al.
Publicado: (2018)

Past, present, and future of long-term treatment for hepatitis B virus
por: Broquetas, Teresa, et al.
Publicado: (2023)

Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma
por: Petruzziello, Arnolfo
Publicado: (2018)

Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition
por: Dandri, Maura, et al.
Publicado: (2021)

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5
por: Cao, Yiyi, et al.
Publicado: (2015)

G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma
por: Lam, Maxine S. Y., et al.
Publicado: (2023)

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy
por: Nguyen, Khanh, et al.
Publicado: (2015)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
por: Ke, Yang, et al.
Publicado: (2013)

Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
por: Xu, Jinghang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4979jqhnhsq89bf6lhli0663if